A Microflow Cytometry-Based Agglutination Immunoassay for Point-of-Care Quantitative Detection of SARS-CoV-2 IgM and IgG

Jianxi Qu, Mathieu Chenier, Yushan Zhang, Chang‐Qing Xu, Jianxi Qu, Mathieu Chenier, Yushan Zhang, Chang‐Qing Xu


Abstract
A rapid, sensitive and simple microflow cytometry-based agglutination immunoassay (MCIA) was developed for point-of-care (POC) quantitative detection of SARS-CoV-2 IgM and IgG antibodies. The antibody concentration was determined by using the transit time of beads aggregates. A linear relationship was established between the average transit time and the concentration of SARS-CoV-2 IgM and IgG, respectively. The limit of detection (LOD) of SARS-CoV-2 IgM and IgG by the MCIA measurement are 0.06 mg/L and 0.10 mg/L, respectively. The 10 µL sample consumption, 30 min assay time and the compact setup make this technique suitable for POC quantitative detection of SARS-CoV-2 antibodies.
Cite:
Jianxi Qu, Mathieu Chenier, Yushan Zhang, Chang‐Qing Xu, Jianxi Qu, Mathieu Chenier, Yushan Zhang, and Chang‐Qing Xu. 2021. A Microflow Cytometry-Based Agglutination Immunoassay for Point-of-Care Quantitative Detection of SARS-CoV-2 IgM and IgG. Micromachines, Volume 12, Issue 4, 12(4):433.
Copy Citation: